Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

PRP is an effective and safe treatment for hair loss in women.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Pigs in farrowing crates and loose-housing systems showed no difference in chronic stress levels as measured by hair cortisol.

Age and other health issues affect erectile dysfunction more than finasteride or alpha-blockers.

PRP treatment may help with alopecia areata, especially in newer cases.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Alopecia areata treatments often don't lead to lasting improvement.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Topical metformin effectively treats melasma with minimal side effects.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.